Table 2 Knowledge about the COVID-19 vaccine among participants vaccinated and unvaccinated against COVID-19
From: Understanding the factors associated with COVID-19 vaccine hesitancy in Venezuela
Knowledge | Total (n = 1,930; 100%) | Vaccinated (n = 1,802; 93.4%) | Unvaccinated (n = 128; 6.6%) | P-value |
|---|---|---|---|---|
Knowledge, mean (SD), points | 7.5 (2.5) | 7.79 (2.33) | 3.94 (1.95) | < 0.001* |
Knowledge, n (%) | ||||
Low (≤ 7 points) | 830 (43.0) | 709 (39.3) | 121 (94.5) | < 0.001† |
Moderate (8–9 points) | 65 (33.7) | 643 (35.7) | 7 (5.5) | < 0.001† |
High (≥ 10 points) | 450 (23.3) | 450 (25) | 0 (0) | < 0.001† |
COVID-19 vaccine decreases the risk of developing severe COVID-19 and dying, correct (%) | 1,596 (82.7) | 1,570 (87.1) | 26 (20.3) | < 0.001† |
COVID-19 vaccine helps protect the community against the virus, correct (%) | 1,565 (81.1) | 1,542 (85.6) | 23 (18) | < 0.001† |
It is possible to become sick with COVID-19 because of vaccination, correct (%) | 675 (35) | 658 (36.5) | 17 (13.3) | < 0.001† |
The COVID-19 vaccine may cause minor side effects, such as fatigue, fever, and malaise, correct (%) | 1,745 (90.4) | 1,642 (91.1) | 103 (80.5) | < 0.001† |
Some COVID-19 vaccines are more effective than others, correct (%) | 1,024 (53.1) | 995 (55.2) | 29 (22.7) | < 0.001† |
Available COVID-19 vaccines are less effective against newer variants of the virus (e.g., Omicron), correct (%) | 672 (34.8) | 632 (35.1) | 40 (31.3) | 0.38† |
Vaccination against COVID-19 has more risks than benefits, correct (%) | 1,350 (69.9) | 1,339 (74.3) | 11 (8.6) | < 0.001† |
Booster doses of COVID-19 vaccine increase protection against the virus, correct (%) | 1,424 (73.8) | 1,407 (78.1) | 17 (13.3) | < 0.001† |
It is recommended that people with risk factors for developing severe COVID-19, such as hypertension and diabetes, be vaccinated against COVID-19, correct (%) | 1,550 (80.3) | 1,504 (83.5) | 46 (35.9) | < 0.001† |
Natural immunity (catching the virus) may be boosted with the COVID-19 vaccine, correct (%) | 1,157 (59.9) | 1,136 (63) | 21 (16.4) | < 0.001† |
Starting at six months of age, all persons may receive the COVID-19 vaccine, such as Pfizer or Moderna, correct (%) | 492 (25.5) | 477 (26.5) | 15 (11.7) | < 0.001† |
Pregnant women may be vaccinated against COVID-19, correct (%) | 1,071 (55.5) | 1,040 (57.7) | 31 (24.2) | < 0.001† |